A revolutionary breakthrough in cataract treatment is on the horizon, with the emergence of C-KAD, a new eye drop therapy.

Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

The bidirectional research examines both laboratory findings and human clinical trial data, revealing that the medicinal use ...

While substantial progress has been made in sharing data from clinical trials, many top-selling medicines still fall short ...

Levine Children's Hospital has several experimental treatments that help families get lifesaving care without having to leave ...

Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help speed up the process of matching potential volunteers to relevant clinical ...

Novotech, the global full-service clinical CRO, has published a new report, Small Cell Lung Cancer: Global Clinical Trial ...

Atrial fibrillation, or Afib, is the most common type of heart arrhythmia. Afib increases your risk of heart attack and ...

The U.S. Department of Labor’s Wage and Hour Division issued an opinion letter on Nov. 8, 2024, affirming that employees may use Family and ...

A Phase 2 trial testing oral ROCK inhibitor Bravyl in people with ALS is now fully enrolled at its highest dosing group.

An AI tool called Muse aims to optimize clinical trial patient recruitment and accelerate the development of new therapies.

A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4- ...